Error message

  • User warning: The following module is missing from the file system: admin_menu. For information about how to fix this, see the documentation page. in _drupal_trigger_error_with_delayed_logging() (line 1138 of /mnt/stor8-wc1-dfw1/408138/www.cannabissativa.co/web/content/includes/bootstrap.inc).
  • Notice: Undefined index: title in TaxonomyDisplayAssociatedDisplayHandlerViews->displayAssociated() (line 60 of /mnt/stor8-wc1-dfw1/408138/www.cannabissativa.co/web/content/sites/all/modules/taxonomy_display/handlers/associated/views.inc).

Pharmaceuticals

9/20 9:00am
CNAB Cannabis, Media, Science, Pharmaceuticals
CFN Media Exclusive Interview with United Cannabis: Developing Anti-Inflammatory Pharmaceuticals
CFN Media Group , the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an exclusive interview with United Cannabis Corp.'s Chief Science Officer ... https://finance.yahoo.com/news/cfn-media-exclusive-interview-united-130000889.ht...
9/19 6:15pm
Cannabis, Pharmaceuticals
Emerald Health Therapeutics Expands its Cannabis Supply with Purchase from Supreme Pharmaceuticals
submitted by /u/uzi_ch [link] [comments] https://www.reddit.com/r/weedstocks/comments/716ltc/emerald_health_therapeutics_...
9/19 6:15pm
Cannabis, Pharmaceuticals
Emerald Health Therapeutics Expands its Cannabis Supply with Purchase from Supreme Pharmaceuticals
submitted by /u/uzi_ch [link] [comments] https://www.reddit.com/r/weedstocks/comments/716ltc/emerald_health_therapeutics_...
9/04 1:31am
SITS Pharmaceuticals
Puffin' with Pauly and Amy Mellen -
This time on Puffin' with Pauly we talk to Amy Mellen, a woman with an incredible story of life transformation. Amy sits down with us to talk about how she got off of major amounts of pharmaceuticals, lost 170 pounds, and more! Amy is a pretty inspiring person, and has some really great things to say... https://vimeo.com/232292241
8/02 8:43am
Marketing, Pharmaceuticals
No more freebies? India plans crackdown on marketing by drugmakers
India, one of the world's largest markets for pharmaceuticals is drawing up its first set of marketing rules for drugmakers, restricting gifts and trips offered to doctors and pharmacists to 1,000 rupees ($15), according to a draft proposal seen by Reuters. Such rules are common overseas, but are not set in stone in India, where campaigners have long demanded a crackdown on unethical selling practices that include gifts ranging from electrical appliances to foreign trips to woo physicians and pharmacists into prescribing and stocking specific medicines. The country has voluntary marketing guidelines for drugmakers, but critics say they are ineffective. https://finance.yahoo.com/news/no-more-freebies-india-plans-124340532.html?.tsrc...
8/01 9:30am
Investors, Pharmaceuticals
GW Pharmaceuticals (GWPH) Q3 Earnings: What Lies in Store?
Investors will likely be looking at GW Pharmaceuticals' (GWPH) progress with its anti-epileptic pipeline candidate, Epidiolex in its fiscal third-quarter results. https://finance.yahoo.com/news/gw-pharmaceuticals-gwph-q3-earnings-133001042.htm...
7/24 7:20pm
Acquisitions, Acquisitions, Beverages, Biotechnology, Cannabis, Foods, Growing, Production, Products, Research, Patents, Pharmaceuticals
US Patent Office Issuing Cannabis Patents
This is a bit dry, but there might be money in these patents one day. Source: https://www.forbes.com/sites/julieweed/2017/07/24/us-patent-office-issuing-cannabis-patents-to-a-growing-market/#31447eae68d4 US Patent Office Issuing Cannabis Patents To A Growing Market Julie Weed , CONTRIBUTOR I cover the legal marijuana industry and its entrepreneurs Opinions expressed by Forbes Contributors are their own. Among the host of uncertainties they face, cannabis industry entrepreneurs might wonder if they can patent marijuana products -- after all, they are still illegal at the federal level. It may come as a relief then, to find out that the US Patent Office has been issuing cannabis-related patents since 1942. Nearly 1,500 cannabis patent applications have been filed, more than half in the last 25 years. About half of the requests were approved and some of those have expired, leaving about 500 currently active cannabis-related patents. David Cohen, PhD, an independent patent agent in... https://www.reddit.com/r/weedstocks/comments/6pc8n6/us_patent_office_issuing_can...
7/24 7:20pm
Acquisitions, Acquisitions, Beverages, Biotechnology, Cannabis, Foods, Growing, Production, Products, Research, Patents, Pharmaceuticals
US Patent Office Issuing Cannabis Patents
This is a bit dry, but there might be money in these patents one day. Source: https://www.forbes.com/sites/julieweed/2017/07/24/us-patent-office-issuing-cannabis-patents-to-a-growing-market/#31447eae68d4 US Patent Office Issuing Cannabis Patents To A Growing Market Julie Weed , CONTRIBUTOR I cover the legal marijuana industry and its entrepreneurs Opinions expressed by Forbes Contributors are their own. Among the host of uncertainties they face, cannabis industry entrepreneurs might wonder if they can patent marijuana products -- after all, they are still illegal at the federal level. It may come as a relief then, to find out that the US Patent Office has been issuing cannabis-related patents since 1942. Nearly 1,500 cannabis patent applications have been filed, more than half in the last 25 years. About half of the requests were approved and some of those have expired, leaving about 500 currently active cannabis-related patents. David Cohen, PhD, an independent patent agent in... https://www.reddit.com/r/weedstocks/comments/6pc8n6/us_patent_office_issuing_can...
7/24 4:42pm
Pharmaceuticals
Why Reata Pharmaceuticals Is Rallying 17.5% Today
Trial results showing mid-stage success for a drug targeting a rare form of chronic kidney disease are sparking interest in the clinical-stage biotech stock. http://finance.yahoo.com/r/cbcb6037-89e8-36a7-84b2-a27d1da064a1/why-reata-pharma...
7/24 3:00pm
Pharmaceuticals
GW Pharmaceuticals to Report Q3 Financial Results and Host Conference Call on 7 August, 2017
LONDON, July 24, 2017-- GW Pharmaceuticals plc,, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, ... https://finance.yahoo.com/news/gw-pharmaceuticals-report-q3-financial-190019710....
7/24 8:42am
EAPH Acquisitions, Acquisitions, Medical Marijuana, Products, Pharmaceuticals
Easton Pharmaceuticals Provides Shareholder Update On Acquisitions, Its Recent MMJ Initiative And Progress On Its Woman's Diagnostics and Treatment Segment
Easton Pharmaceuticals Inc. provides shareholder update on new and existing acquisitions including its medical marijuana venture and progress on its woman's diagnostics and treatment segment products. https://finance.yahoo.com/news/easton-pharmaceuticals-provides-shareholder-acqui...
6/21 8:00am
Research, Pharmaceuticals
Biotech Industry Showing Signs of a Revival in 2017: Today's Research on GW Pharmaceuticals and ZIOPHARM Oncology
NEW YORK, NY / ACCESSWIRE / June 21, 2017 / The Biotech Industry has continued to outperform the broader markets in 2017. Biotech companies appear to be benefitting from a speedier FDA approval process ... https://finance.yahoo.com/news/biotech-industry-showing-signs-revival-120000194....
6/19 12:26pm
Pharmaceuticals
GSK's new pharma head to join in September after AstraZeneca tussle
GlaxoSmithKline has struck a deal for Luke Miels to start as its new head of pharmaceuticals in September, following a lengthy dispute over his contract with his former employer AstraZeneca. Britain's biggest drugmaker poached Miels in January in the first major appointment by incoming GSK Chief Executive Emma Walmsley. GSK said on Monday it had now struck an agreement with AstraZeneca for Miels to start on Sept. 4, avoiding the need for a court case over his contract. https://finance.yahoo.com/news/gsk-pharma-head-sept-astrazeneca-154611350.html
6/19 12:26pm
Pharmaceuticals
GSK's new pharma head to join in September after AstraZeneca tussle
GlaxoSmithKline has struck a deal for Luke Miels to start as its new head of pharmaceuticals in September, following a lengthy dispute over his contract with his former employer AstraZeneca. Britain's biggest drugmaker poached Miels in January in the first major appointment by incoming GSK Chief Executive Emma Walmsley. GSK said on Monday it had now struck an agreement with AstraZeneca for Miels to start on Sept. 4, avoiding the need for a court case over his contract. https://finance.yahoo.com/news/gsk-pharma-head-sept-astrazeneca-154611350.html
6/19 12:26pm
Pharmaceuticals
GSK's new pharma head to join in September after AstraZeneca tussle
GlaxoSmithKline has struck a deal for Luke Miels to start as its new head of pharmaceuticals in September, following a lengthy dispute over his contract with his former employer AstraZeneca. Britain's biggest drugmaker poached Miels in January in the first major appointment by incoming GSK Chief Executive Emma Walmsley. GSK said on Monday it had now struck an agreement with AstraZeneca for Miels to start on Sept. 4, avoiding the need for a court case over his contract. https://finance.yahoo.com/news/gsk-pharma-head-sept-astrazeneca-154611350.html
6/19 12:26pm
Pharmaceuticals
GSK's new pharma head to join in September after AstraZeneca tussle
GlaxoSmithKline has struck a deal for Luke Miels to start as its new head of pharmaceuticals in September, following a lengthy dispute over his contract with his former employer AstraZeneca. Britain's biggest drugmaker poached Miels in January in the first major appointment by incoming GSK Chief Executive Emma Walmsley. GSK said on Monday it had now struck an agreement with AstraZeneca for Miels to start on Sept. 4, avoiding the need for a court case over his contract. https://finance.yahoo.com/news/gsk-pharma-head-sept-astrazeneca-154611350.html
6/19 9:16am
Pharmaceuticals
IIROC Trade Resumption
Vancouver, British Columbia--(Newsfile Corp. - June 19, 2017) - Trading resumes in: Company: Supreme Pharmaceuticals Inc. TSX-V Symbol: FIRE ... https://finance.yahoo.com/news/iiroc-trade-resumption-supreme-pharmaceuticals-13...
6/16 3:23pm
ARNA Pharmaceuticals
ETFs with exposure to Arena Pharmaceuticals, Inc. : June 16, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Arena Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ARNA-US. Comparing the performance and risk of Arena Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...) http://finance.yahoo.com/r/e7e4c320-d0ae-31d8-90e9-f60010bff005/etfs-with-exposu...
6/16 1:33pm
Pharmaceuticals
IIROC Trade Halt
Vancouver, British Columbia--(Newsfile Corp. - June 16, 2017) - The following issues have been halted by IIROC: Company: Supreme Pharmaceuticals Inc. TSX-V Symbol: FIRE ... https://finance.yahoo.com/news/iiroc-trade-halt-supreme-pharmaceuticals-17330071...
6/16 1:30pm
News, Pharmaceuticals
[NEWS] Supreme Pharmaceuticals Inc trading halt
Supreme Pharmaceuticals Inc submitted by /u/method76 [link] [comments] https://www.reddit.com/r/weedstocks/comments/6ho0ik/news_supreme_pharmaceuticals...
6/16 8:36am
ARNA Pharmaceuticals
Arena Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ARNA-US : June 16, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Arena Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...) http://finance.yahoo.com/r/55a50a18-8d1c-3f19-bb8e-b8bb970bfa7f/arena-pharmaceut...
6/16 8:24am
Pharmaceuticals
5 Critical Questions for One of the Biggest Marijuana Stocks on the Market
GW Pharmaceuticals executives answer some big questions at the Goldman Sachs healthcare conference. http://finance.yahoo.com/r/68d0673e-47b5-32e6-88f3-4ddc41b77f08/5-critical-quest...
6/16 8:00am
ARNA Research, Pharmaceuticals
Biotech Industry Showing Signs of a Revival in 2017: Today's Research on Adamis Pharmaceuticals and Arena Pharmaceuticals
NEW YORK, NY / ACCESSWIRE / June 16, 2017 / The Biotech Industry has continued to outperform the broader markets till now in 2017. Biotech companies appear to be benefiting from a speedier FDA approval ... https://finance.yahoo.com/news/biotech-industry-showing-signs-revival-120000142....
6/15 8:30am
ARNA Pharmaceuticals
Arena Pharmaceuticals to Present at JMP Securities Life Sciences Conference
SAN DIEGO , June 15, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), today announced that Amit Munshi , the Company's President and Chief Executive Officer, will present a corporate update ... https://finance.yahoo.com/news/arena-pharmaceuticals-present-jmp-securities-1230...
6/14 4:01pm
ARNA Stock Split, Pharmaceuticals
Arena Pharmaceuticals Announces Shareholders and Board of Directors Approve Reverse Stock Split
SAN DIEGO, June 14, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA), today announced that at the annual meeting of stockholders, held June 13, 2017, stockholders voted to approve a proposal authorizing the Board of Directors of the Company to amend the Company's certificate of incorporation to effect a reverse stock split of Arena's outstanding common shares at an exchange ratio of 1-for-10, and a change in the number of authorized shares of common stock to 73.5 million shares. Arena's Board of Directors had previously directed that the proposal be submitted to the shareholders for approval and has subsequently determined that the reverse stock split will take effect at 5:00pm ET on June 16, 2017. Beginning with the opening of trading on June 19, 2017, the Company's common stock will trade on a split-adjusted basis. https://finance.yahoo.com/news/arena-pharmaceuticals-announces-shareholders-boar...